Therapeutic efficacy of different iron chelators in Egyptian children with Beta Thalassemia with iron overload

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 15, Iss. 2, 2015-01 ,pp. : 98-105

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody Penetration Into Living Cells: Pathogenic, Preventive and Immuno-Therapeutic Implications

By  

Current Pharmaceutical Design, Vol. 9, Iss. 23, 2003-09 ,pp. : 1881-1887

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 12, 2014-12 ,pp. : 1125-1140

Bentham Science Publishers

Access to resources Recommend Favorite

Benefits and Risks of Deferiprone in Iron Overload in Thalassaemia and Other Conditions: Comparison of Epidemiological and Therapeutic Aspects with Deferoxamine

By Kontoghiorghes G.J.   Neocleous K.   Kolnagou A.  

Drug Safety, Vol. 26, Iss. 8, 2003-01 ,pp. : 553-584

Adis International

Access to resources Recommend Favorite

The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders: Therapeutic Implications

By Perry G.   Sayre L.M.   Atwood C.S.   Castellani R.J.   Cash A.D.   Rottkamp C.A.   Smith M.A.  

CNS Drugs, Vol. 16, Iss. 5, 2002-01 ,pp. : 339-352

Adis International

Access to resources Recommend Favorite